I’m taking some time during a quiet week at work for my EUPATI studies, a on-line training program for patient and family advocates about medicines research and development. This mornings’s lesson is pharmacovigilance — the complex science of preventing adverse effects toward medication. An important topic about which I know little, but from which we …